Advances in techniques for detecting circulating tumor cells

Chinese Journal of Clinical Oncology

Volumn 39, Issue 22, 2012, Pages 1859-1863

  Song, Yingjian ^a   Ji, Ling ^a   Yang, Lin ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Circulating tumor cells (CTCs); Detection; Tumor metastasis

Indexed keywords

BIOTECHNOLOGICAL PROCEDURES; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER THERAPY; CIRCULATING TUMOR CELL; DIAGNOSTIC ACCURACY; DISTANT METASTASIS; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; PERSONALIZED MEDICINE; REVIEW;

EID: 84872296226     PISSN: 10008179     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1000-8179.2012.22.042     Document Type: Review

References (22)

1. Ashworth TR. A case of cancer in which cells similar to those in the tumors were seen in the blood after death[J]. Aust Med J, 1869,14:146-147.
2. Hou JM, Krebs MG, Lancashire L, et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer[J]. J Clin Oncol, 2012,30(5):525-532.
3. krebs MG, Sloane R, Priest L, et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer[J]. J Clin Oncol, 2011,29(12):1556-1563.
4. Bai H, Wang Z, Chen K, et al. Influence of chemotherapy on EGFR mutation status among patients with non-small-cell lung cancer [J]. J Clin Oncol, 2012,30(25):3077-3083.
5. Hayes GM, Busch R, Voogt J, et al. Isolation of malignant B cells from patients with chronic lymphocytic leukemia (CLL) for analysis of cell proliferation: validation of a simplified method suitable for multi-center clinical studies[J]. Leuk Res, 2010,34(6):809-815.
6. Desitter I, Guerrouahen BS, Benali-Furet N, et al. A new device for rapid isolation by size and characterization of rare circulating tumor cells[J]. Anticancer Res, 2011,31(2):427-441.
7. Lin HK, Zheng S, Williams AJ, et al. Portable filter-based microdevice for detection and characterization of circulating tumor cells[J]. Clin Cancer Res, 2010,16(20):5011-5018.
8. Tewes M, Aktas B, Welt A, et al. Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies[J]. Breast Cancer Res Treat, 2009,115(3):581-590.
9. Moinar B, Sipos F, Galamb O, et al. Molecular detection of circulating cancer cells. Role in diagnosis, prognosis and follow-up of colon cancer patients[J]. Dig Dis, 2003,21(4):320-325. (Pubitemid 38209789)
10. Dietz L, Bruce R. Advances in optical technologies for rare cell detection and characterization[J]. Recent Results Cancer Res, 2012,195:77-85.
11. Schwarzenbach H, Chun FK, Lange I, et al. Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer[J]. Int J Cancer, 2007,120(7):1465-1471. (Pubitemid 46355381)
12. Chen TF, Jiang GL, Fu XL, et al. CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor[J]. Lung Cancer, 2007,56(1):105-114.
13. Todenhöfer T, Hennenlotter J, Feyerabend S, et al. Preliminary experience on the use of the Adnatest® system for detection of circulating tumor cells in prostate cancer patients[J]. Anticancer Res, 2012,32(8):3507- 3513.
14. Balic M, Dandachi N, Hofmann G, et al. Comparison of two methods for enumerating circulating tumor cells in carcinoma patients[J]. Cytometry B Clin Cytom, 2005,68(1):25-30. (Pubitemid 41566360)
15. Stott SL, Hsu CH, Tsukrov DI, et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip[J]. Proc Natl Acad Sci USA, 2010,107(43):18392-18397.
16. Alix-Panabières C. EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients[J]. Recent Results Cancer Res, 2012,195:69-76.
17. De Wever O, Pauwels P, De Craene B, et al. Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front[J]. Histochem Cell Biol, 2008,130(3):481-494.
18. Iwatsuki M, Mimori K, Yokobori T, et al. Epithelial-mesenchymal transition in cancer development and its clinical significance[J]. Cancer Sci, 2010,101(2):293-299.
19. Tanaka F, Yoneda K, Kondo N, et al. Circulating tumor cell as a diagnostic marker in primary lung cancer[J]. Clin Cancer Res, 2009,15(22):6980-6986.
20. Hou JM, Greystoke A, Lancashire L, et al. Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy[J]. Am J Pathol, 2009,175(2):808-816.
21. Maheswaran S, Sequist LV, Nagrath S, et al. Detection of mutations in EGFR in circulating lung-cancer cells[J]. N Engl J Med, 2008,359(4):366-377.
22. Balic M, Lin H, Williams A, et al. Progress in circulating tumor cell capture and analysis: implications for cancer management[J]. Expert Rev Mol Diagn, 2012,12(3):303-312.